Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?

During the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector. Since then, many policies as well as regulatory and financial initiatives have been designed by the government to achieve that goal. As a result, Canad...

Full description

Saved in:
Bibliographic Details
Main Author: Marie-Hélène Bacon
Format: Article
Language:fra
Published: Éditions en environnement VertigO 2009-11-01
Series:VertigO
Subjects:
Online Access:https://journals.openedition.org/vertigo/8915
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850080434568822784
author Marie-Hélène Bacon
author_facet Marie-Hélène Bacon
author_sort Marie-Hélène Bacon
collection DOAJ
description During the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector. Since then, many policies as well as regulatory and financial initiatives have been designed by the government to achieve that goal. As a result, Canada is today among the firsts countries in the world in terms of hectares of genetically modified (GM) crops. Within these multiple fields of GM crops grows, since 1994, transgenic plants which could eventually produce pharmaceutical molecules.  Called pharma-crops, these new genetically modified organisms (GMO) could, among many other things, contaminate the food system and the environment. We have learned from recent events related to GM crops that in the actual scientific and regulatory context, no biological, physical or political limits seems to be able to contain effectively transgenic contamination. As such, pharma-crops could generate health, environmental and socioeconomic impacts which would spread beyond the Canadian territory.Despite that, the Canadian government and his regulatory agencies such as the Canadian Food Inspection Agency maintain that they can, at the same time, stimulate economical grow and protect the population’s health and the environment. The analysis of the policies and regulations in Canada underline that the economical goal actually  jeopardise the regulatory  process and the scientific evaluation of pharma-crops and thus, put at stake the protection of the populations and the environment.
format Article
id doaj-art-3020b16052254606a9cf0d20f819e3cc
institution DOAJ
issn 1492-8442
language fra
publishDate 2009-11-01
publisher Éditions en environnement VertigO
record_format Article
series VertigO
spelling doaj-art-3020b16052254606a9cf0d20f819e3cc2025-08-20T02:44:56ZfraÉditions en environnement VertigOVertigO1492-84422009-11-016Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?Marie-Hélène BaconDuring the years 1980’s, the Canadian government decided to stimulate the development of biotechnologies in order to become a leader in this sector. Since then, many policies as well as regulatory and financial initiatives have been designed by the government to achieve that goal. As a result, Canada is today among the firsts countries in the world in terms of hectares of genetically modified (GM) crops. Within these multiple fields of GM crops grows, since 1994, transgenic plants which could eventually produce pharmaceutical molecules.  Called pharma-crops, these new genetically modified organisms (GMO) could, among many other things, contaminate the food system and the environment. We have learned from recent events related to GM crops that in the actual scientific and regulatory context, no biological, physical or political limits seems to be able to contain effectively transgenic contamination. As such, pharma-crops could generate health, environmental and socioeconomic impacts which would spread beyond the Canadian territory.Despite that, the Canadian government and his regulatory agencies such as the Canadian Food Inspection Agency maintain that they can, at the same time, stimulate economical grow and protect the population’s health and the environment. The analysis of the policies and regulations in Canada underline that the economical goal actually  jeopardise the regulatory  process and the scientific evaluation of pharma-crops and thus, put at stake the protection of the populations and the environment.https://journals.openedition.org/vertigo/8915economyenvironmentpublic policiesPharma-cropsGMObiopharmaceutical
spellingShingle Marie-Hélène Bacon
Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
VertigO
economy
environment
public policies
Pharma-crops
GMO
biopharmaceutical
title Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
title_full Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
title_fullStr Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
title_full_unstemmed Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
title_short Environnement politique et réglementaire des pharmacultures au Canada : la contamination pharmaceutique à l’horizon ?
title_sort environnement politique et reglementaire des pharmacultures au canada la contamination pharmaceutique a l horizon
topic economy
environment
public policies
Pharma-crops
GMO
biopharmaceutical
url https://journals.openedition.org/vertigo/8915
work_keys_str_mv AT mariehelenebacon environnementpolitiqueetreglementairedespharmaculturesaucanadalacontaminationpharmaceutiquealhorizon